This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, including antipsychotics and antidepressants. Its structure, featuring a trifluoroethyl group and an aminopiperidine moiety, makes it a valuable building block for designing molecules with enhanced binding affinity and metabolic stability. Additionally, it is employed in research settings for the exploration of novel therapeutic agents, particularly in the field of neuropharmacology.